2020
DOI: 10.3791/61503-v
|View full text |Cite
|
Sign up to set email alerts
|

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Suarez-Cuenca et al 6 presented a protocol for the quantification of circulating mononuclear progenitor cells (MPCs) from vessels close to the angioplasty site, in order to predict the risk of limb amputation in patients with critical limb ischemia (CLI). This is another interesting topic, since the risk of amputation in CLI nowadays is still very high 7 , and there is a substantial lack of available predictive models 8 .…”
mentioning
confidence: 99%
“…Suarez-Cuenca et al 6 presented a protocol for the quantification of circulating mononuclear progenitor cells (MPCs) from vessels close to the angioplasty site, in order to predict the risk of limb amputation in patients with critical limb ischemia (CLI). This is another interesting topic, since the risk of amputation in CLI nowadays is still very high 7 , and there is a substantial lack of available predictive models 8 .…”
mentioning
confidence: 99%
“…Suarez-Cuenca et al 6 presented a protocol for the quantification of circulating mononuclear progenitor cells (MPCs) from vessels close to the angioplasty site, in order to predict the risk of limb amputation in patients with critical limb ischemia (CLI). This is another interesting topic, since the risk of amputation in CLI nowadays is still very high 7 , and there is a substantial lack of available predictive models 8 .…”
mentioning
confidence: 99%